Jump to content

TSC1

From Wikipedia, the free encyclopedia

This is an old revision of this page, as edited by Nicmrgn (talk | contribs) at 18:48, 28 August 2016 (→‎Function: spelling correction). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

TSC1
Available structures
PDBOrtholog search: PDBe RCSB
Identifiers
AliasesTSC1, LAM, TSC, tuberous sclerosis 1, TSC complex subunit 1
External IDsOMIM: 605284; MGI: 1929183; HomoloGene: 314; GeneCards: TSC1; OMA:TSC1 - orthologs
Orthologs
SpeciesHumanMouse
Entrez

7248

64930

Ensembl

ENSG00000165699

ENSMUSG00000026812

UniProt

Q92574

Q9EP53

RefSeq (mRNA)

NM_000368
NM_001008567
NM_001162426
NM_001162427
NM_001362177

NM_022887
NM_001289575
NM_001289576

RefSeq (protein)

NP_000359
NP_001155898
NP_001155899
NP_001349106

NP_001276504
NP_001276505
NP_075025

Location (UCSC)Chr 9: 132.89 – 132.95 MbChr 2: 28.53 – 28.58 Mb
PubMed search[3][4]
Wikidata
View/Edit HumanView/Edit Mouse

Tuberous sclerosis 1 (TSC1), also known as Hamartin, is a protein that in humans is encoded by the TSC1 gene.[5]

Function

TSC1 forms a multi-protein complex with TSC2 and TBC1D7 known as the TSC complex. This complex negatively regulates mTORC1 signaling by functioning as a GTPase-activating protein (GAP) for the small GTPase Rheb, an essential activator of mTORC1. The TSC complex has been implicated as a tumor suppressor.

Clinical significance

Defects in this gene can cause tuberous sclerosis, due to a functional impairment of the TSC complex.[citation needed] Defects in TSC1 may also be a cause of focal cortical dysplasia.[citation needed] TSC1 may be involved in protecting brain neurons in the CA3 region of the hippocampus from the effects of stroke.[6]

Interactions

TSC1 has been shown to interact with:

See also

References

  1. ^ a b c GRCh38: Ensembl release 89: ENSG00000165699 – Ensembl, May 2017
  2. ^ a b c GRCm38: Ensembl release 89: ENSMUSG00000026812 – Ensembl, May 2017
  3. ^ "Human PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
  4. ^ "Mouse PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
  5. ^ "Entrez Gene: TSC1 tuberous sclerosis 1".
  6. ^ Papadakis M, Hadley G, Xilouri M, Hoyte LC, Nagel S, McMenamin MM, Tsaknakis G, Watt SM, Drakesmith CW, Chen R, Wood MJ, Zhao Z, Kessler B, Vekrellis K, Buchan AM (March 2013). "Tsc1 (hamartin) confers neuroprotection against ischemia by inducing autophagy". Nat. Med. 19 (3): 351–7. doi:10.1038/nm.3097. PMID 23435171.
  7. ^ Roux PP, Ballif BA, Anjum R, Gygi SP, Blenis J (2004). "Tumor-promoting phorbol esters and activated Ras inactivate the tuberous sclerosis tumor suppressor complex via p90 ribosomal S6 kinase". Proc. Natl. Acad. Sci. U.S.A. 101 (37): 13489–94. doi:10.1073/pnas.0405659101. PMC 518784. PMID 15342917.
  8. ^ a b Dan HC, Sun M, Yang L, Feldman RI, Sui XM, Ou CC, Nellist M, Yeung RS, Halley DJ, Nicosia SV, Pledger WJ, Cheng JQ (2002). "Phosphatidylinositol 3-kinase/Akt pathway regulates tuberous sclerosis tumor suppressor complex by phosphorylation of tuberin". J. Biol. Chem. 277 (38): 35364–70. doi:10.1074/jbc.M205838200. PMID 12167664.{{cite journal}}: CS1 maint: unflagged free DOI (link)
  9. ^ Haddad LA, Smith N, Bowser M, Niida Y, Murthy V, Gonzalez-Agosti C, Ramesh V (2002). "The TSC1 tumor suppressor hamartin interacts with neurofilament-L and possibly functions as a novel integrator of the neuronal cytoskeleton". J. Biol. Chem. 277 (46): 44180–6. doi:10.1074/jbc.M207211200. PMID 12226091.{{cite journal}}: CS1 maint: unflagged free DOI (link)
  10. ^ a b Astrinidis A, Senapedis W, Henske EP (2006). "Hamartin, the tuberous sclerosis complex 1 gene product, interacts with polo-like kinase 1 in a phosphorylation-dependent manner". Hum. Mol. Genet. 15 (2): 287–97. doi:10.1093/hmg/ddi444. PMID 16339216.
  11. ^ Hodges AK, Li S, Maynard J, Parry L, Braverman R, Cheadle JP, DeClue JE, Sampson JR (2001). "Pathological mutations in TSC1 and TSC2 disrupt the interaction between hamartin and tuberin". Hum. Mol. Genet. 10 (25): 2899–905. doi:10.1093/hmg/10.25.2899. PMID 11741833.
  12. ^ Aicher LD, Campbell JS, Yeung RS (2001). "Tuberin phosphorylation regulates its interaction with hamartin. Two proteins involved in tuberous sclerosis". J. Biol. Chem. 276 (24): 21017–21. doi:10.1074/jbc.C100136200. PMID 11290735.{{cite journal}}: CS1 maint: unflagged free DOI (link)
  13. ^ van Slegtenhorst M, Nellist M, Nagelkerken B, Cheadle J, Snell R, van den Ouweland A, Reuser A, Sampson J, Halley D, van der Sluijs P (1998). "Interaction between hamartin and tuberin, the TSC1 and TSC2 gene products". Hum. Mol. Genet. 7 (6): 1053–7. doi:10.1093/hmg/7.6.1053. PMID 9580671.
  14. ^ Nellist M, Goedbloed MA, de Winter C, Verhaaf B, Jankie A, Reuser AJ, van den Ouweland AM, van der Sluijs P, Halley DJ (2002). "Identification and characterization of the interaction between tuberin and 14-3-3zeta". J. Biol. Chem. 277 (42): 39417–24. doi:10.1074/jbc.M204802200. PMID 12176984.{{cite journal}}: CS1 maint: unflagged free DOI (link)
  15. ^ Li Y, Inoki K, Guan KL (2004). "Biochemical and functional characterizations of small GTPase Rheb and TSC2 GAP activity". Mol. Cell. Biol. 24 (18): 7965–75. doi:10.1128/MCB.24.18.7965-7975.2004. PMC 515062. PMID 15340059.
  16. ^ Mak BC, Takemaru K, Kenerson HL, Moon RT, Yeung RS (2003). "The tuberin-hamartin complex negatively regulates beta-catenin signaling activity". J. Biol. Chem. 278 (8): 5947–51. doi:10.1074/jbc.C200473200. PMID 12511557.{{cite journal}}: CS1 maint: unflagged free DOI (link)
  17. ^ Ma L, Chen Z, Erdjument-Bromage H, Tempst P, Pandolfi PP (2005). "Phosphorylation and functional inactivation of TSC2 by Erk implications for tuberous sclerosis and cancer pathogenesis". Cell. 121 (2): 179–93. doi:10.1016/j.cell.2005.02.031. PMID 15851026.
  18. ^ Cai SL, Tee AR, Short JD, Bergeron JM, Kim J, Shen J, Guo R, Johnson CL, Kiguchi K, Walker CL (2006). "Activity of TSC2 is inhibited by AKT-mediated phosphorylation and membrane partitioning". J. Cell Biol. 173 (2): 279–89. doi:10.1083/jcb.200507119. PMC 2063818. PMID 16636147.
  19. ^ Cao Y, Kamioka Y, Yokoi N, Kobayashi T, Hino O, Onodera M, Mochizuki N, Nakae J (2006). "Interaction of FoxO1 and TSC2 induces insulin resistance through activation of the mammalian target of rapamycin/p70 S6K pathway". J. Biol. Chem. 281 (52): 40242–51. doi:10.1074/jbc.M608116200. PMID 17077083.{{cite journal}}: CS1 maint: unflagged free DOI (link)
  20. ^ Inoki K, Zhu T, Guan KL (2003). "TSC2 mediates cellular energy response to control cell growth and survival". Cell. 115 (5): 577–90. doi:10.1016/S0092-8674(03)00929-2. PMID 14651849.
  21. ^ Nellist M, Burgers PC, van den Ouweland AM, Halley DJ, Luider TM (2005). "Phosphorylation and binding partner analysis of the TSC1-TSC2 complex". Biochem. Biophys. Res. Commun. 333 (3): 818–26. doi:10.1016/j.bbrc.2005.05.175. PMID 15963462.
  22. ^ Goncharova EA, Goncharov DA, Spaits M, Noonan DJ, Talovskaya E, Eszterhas A, Krymskaya VP (2006). "Abnormal growth of smooth muscle-like cells in lymphangioleiomyomatosis: Role for tumor suppressor TSC2". Am. J. Respir. Cell Mol. Biol. 34 (5): 561–72. doi:10.1165/rcmb.2005-0300OC. PMC 2644221. PMID 16424383.
  23. ^ Astrinidis A, Senapedis W, Coleman TR, Henske EP (2003). "Cell cycle-regulated phosphorylation of hamartin, the product of the tuberous sclerosis complex 1 gene, by cyclin-dependent kinase 1/cyclin B". J. Biol. Chem. 278 (51): 51372–9. doi:10.1074/jbc.M303956200. PMID 14551205.{{cite journal}}: CS1 maint: unflagged free DOI (link)
  24. ^ Nellist M, Verhaaf B, Goedbloed MA, Reuser AJ, van den Ouweland AM, Halley DJ (2001). "TSC2 missense mutations inhibit tuberin phosphorylation and prevent formation of the tuberin-hamartin complex". Hum. Mol. Genet. 10 (25): 2889–98. doi:10.1093/hmg/10.25.2889. PMID 11741832.
  25. ^ Benvenuto G, Li S, Brown SJ, Braverman R, Vass WC, Cheadle JP, Halley DJ, Sampson JR, Wienecke R, DeClue JE (2000). "The tuberous sclerosis-1 (TSC1) gene product hamartin suppresses cell growth and augments the expression of the TSC2 product tuberin by inhibiting its ubiquitination". Oncogene. 19 (54): 6306–16. doi:10.1038/sj.onc.1204009. PMID 11175345.
  26. ^ Murthy V, Haddad LA, Smith N, Pinney D, Tyszkowski R, Brown D, Ramesh V (2000). "Similarities and differences in the subcellular localization of hamartin and tuberin in the kidney". Am. J. Physiol. Renal Physiol. 278 (5): F737-46. PMID 10807585.
  27. ^ Miloloza A, Rosner M, Nellist M, Halley D, Bernaschek G, Hengstschläger M (2000). "The TSC1 gene product, hamartin, negatively regulates cell proliferation". Hum. Mol. Genet. 9 (12): 1721–7. doi:10.1093/hmg/9.12.1721. PMID 10915759.

Further reading

  • Hengstschläger M (2002). "Tuberous sclerosis complex genes: from flies to human genetics". Arch. Dermatol. Res. 293 (8): 383–6. doi:10.1007/s004030100250. PMID 11686512.
  • Ramesh V (2004). "Aspects of tuberous sclerosis complex (TSC) protein function in the brain". Biochem. Soc. Trans. 31 (Pt 3): 579–83. doi:10.1042/BST0310579. PMID 12773159.
  • Knowles MA, Hornigold N, Pitt E (2004). "Tuberous sclerosis complex (TSC) gene involvement in sporadic tumours". Biochem. Soc. Trans. 31 (Pt 3): 597–602. doi:10.1042/BST0310597. PMID 12773163.
  • Ellisen LW (2007). "Growth control under stress: mTOR regulation through the REDD1-TSC pathway". Cell Cycle. 4 (11): 1500–02. doi:10.4161/cc.4.11.2139. PMID 16258273.
  • Jozwiak J, Jozwiak S (2007). "Giant cells: contradiction to two-hit model of tuber formation?". Cell. Mol. Neurobiol. 27 (2): 251–61. doi:10.1007/s10571-006-9106-0. PMID 16897363.
  • Nagase T, Seki N, Ishikawa K, et al. (1997). "Prediction of the coding sequences of unidentified human genes. VI. The coding sequences of 80 new genes (KIAA0201-KIAA0280) deduced by analysis of cDNA clones from cell line KG-1 and brain". DNA Res. 3 (5): 321–9, 341–54. doi:10.1093/dnares/3.5.321. PMID 9039502.
  • van Slegtenhorst M, de Hoogt R, Hermans C, et al. (1997). "Identification of the tuberous sclerosis gene TSC1 on chromosome 9q34". Science. 277 (5327): 805–8. doi:10.1126/science.277.5327.805. PMID 9242607.
  • Jones AC, Daniells CE, Snell RG, et al. (1997). "Molecular genetic and phenotypic analysis reveals differences between TSC1 and TSC2 associated familial and sporadic tuberous sclerosis". Hum. Mol. Genet. 6 (12): 2155–61. doi:10.1093/hmg/6.12.2155. PMID 9328481.
  • van Slegtenhorst M, Nellist M, Nagelkerken B, et al. (1998). "Interaction between hamartin and tuberin, the TSC1 and TSC2 gene products". Hum. Mol. Genet. 7 (6): 1053–7. doi:10.1093/hmg/7.6.1053. PMID 9580671.
  • Plank TL, Yeung RS, Henske EP (1998). "Hamartin, the product of the tuberous sclerosis 1 (TSC1) gene, interacts with tuberin and appears to be localized to cytoplasmic vesicles". Cancer Res. 58 (21): 4766–70. PMID 9809973.
  • Kwiatkowska J, Jozwiak S, Hall F, et al. (1999). "Comprehensive mutational analysis of the TSC1 gene: observations on frequency of mutation, associated features, and nonpenetrance". Ann. Hum. Genet. 62 (Pt 4): 277–85. doi:10.1046/j.1469-1809.1998.6240277.x. PMID 9924605.
  • van Slegtenhorst M, Verhoef S, Tempelaars A, et al. (1999). "Mutational spectrum of the TSC1 gene in a cohort of 225 tuberous sclerosis complex patients: no evidence for genotype-phenotype correlation". J. Med. Genet. 36 (4): 285–9. doi:10.1136/jmg.36.4.285. PMC 1734341. PMID 10227394.
  • Niida Y, Lawrence-Smith N, Banwell A, et al. (2000). "Analysis of both TSC1 and TSC2 for germline mutations in 126 unrelated patients with tuberous sclerosis". Hum. Mutat. 14 (5): 412–22. doi:10.1002/(SICI)1098-1004(199911)14:5<412::AID-HUMU7>3.0.CO;2-K. PMID 10533067.
  • Zhang H, Nanba E, Yamamoto T, et al. (2000). "Mutational analysis of TSC1 and TSC2 genes in Japanese patients with tuberous sclerosis complex". J. Hum. Genet. 44 (6): 391–6. doi:10.1007/s100380050185. PMID 10570911.
  • Nellist M, van Slegtenhorst MA, Goedbloed M, et al. (2000). "Characterization of the cytosolic tuberin-hamartin complex. Tuberin is a cytosolic chaperone for hamartin". J. Biol. Chem. 274 (50): 35647–52. doi:10.1074/jbc.274.50.35647. PMID 10585443.{{cite journal}}: CS1 maint: unflagged free DOI (link)
  • Yamashita Y, Ono J, Okada S, et al. (2000). "Analysis of all exons of TSC1 and TSC2 genes for germline mutations in Japanese patients with tuberous sclerosis: report of 10 mutations". Am. J. Med. Genet. 90 (2): 123–6. doi:10.1002/(SICI)1096-8628(20000117)90:2<123::AID-AJMG7>3.0.CO;2-L. PMID 10607950.
  • Lamb RF, Roy C, Diefenbach TJ, et al. (2000). "The TSC1 tumour suppressor hamartin regulates cell adhesion through ERM proteins and the GTPase Rho". Nat. Cell Biol. 2 (5): 281–7. doi:10.1038/35010550. PMID 10806479.
  • Miloloza A, Rosner M, Nellist M, et al. (2000). "The TSC1 gene product, hamartin, negatively regulates cell proliferation". Hum. Mol. Genet. 9 (12): 1721–7. doi:10.1093/hmg/9.12.1721. PMID 10915759.
  • Murthy V, Stemmer-Rachamimov AO, Haddad LA, et al. (2001). "Developmental expression of the tuberous sclerosis proteins tuberin and hamartin". Acta Neuropathol. 101 (3): 202–10. doi:10.1007/s004010000269. PMID 11307618.
  • Catania MG, Mischel PS, Vinters HV (2001). "Hamartin and tuberin interaction with the G2/M cyclin-dependent kinase CDK1 and its regulatory cyclins A and B.". J. Neuropathol. Exp. Neurol. 60 (7): 711–23. PMID 11444800.
Retrieved from "https://en.wikipedia.org/w/index.php?title=TSC1&oldid=736619066"